Latest Breaking News On - Carmen vroonen - Page 5 : comparemela.com
Galapagos NV: Extension of lock-up period in Gilead-Galapagos collaboration agreement
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Investegate |Galapagos NV Announcements | Galapagos NV: Extension of lock-up period in Gilead-Galapagos collaboration agreement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Investegate |Galapagos NV Announcements | Galapagos NV: Galapagos appoints Bart Filius as President and Chief Operating Officer
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
Galapagos NV: Transparency notification received from The Capital Group
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Galapagos NV: Pipeline and capital for growth
Jyseleca approved for rheumatoid arthritis (RA) in Europe & Japan
Gilead decided not to pursue the RA indication in the U.S. as a result of Complete Response Letter (CRL) from the Food and Drug Administration (FDA)
Galapagos to assume commercialization of Jyseleca in Europe by the end of 2021, first sales achieved
Primary endpoint achieved in SELECTION Phase 3 trial in ulcerative colitis (UC) with Jyseleca, submitted for approval in UC in Europe
Positive topline results in PINTA Phase 2 trial with 1205 in idiopathic pulmonary fibrosis (IPF); no signal with 1972 in ROCCELLA Phase 2b trial in osteoarthritis (OA)